March 24, 2022 Comments Off on New patent for Genentech Inc drug GAVRETO Posted in: Patent Added Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Genentech Inc drug GAVRETO appeared first on DrugPatentWa…
March 24, 2022 Comments Off on New patent for Pfizer drug XELJANZ XR Posted in: Patent Added Annual Drug Patent Expirations for XELJANZ+XR Xeljanz Xr is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent for Pfizer drug XELJANZ XR appeared first on DrugPatentWat…
